CS logo
small CS logo
Kumamoto Shinto General Hospital; Breast Cancer Center

Kumamoto, Japan
Private hospital in Kumamoto
3 Chome-2-65 Oe, Chuo Ward, Kumamoto, 862-8655

About Kumamoto Shinto General Hospital; Breast Cancer Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Genentech, Inc.
1
Total Rows: 2

Clinical Trials at Kumamoto Shinto General Hospital; Breast Cancer Center


During the past decade, Kumamoto Shinto General Hospital; Breast Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846

Rows per page:

1–3 of 3

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Kumamoto Shinto General Hospital; Breast Cancer Center" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 2Hoffmann-La Roche: 2Genentech, Inc.: 1Genentech, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsBreast International Group: 1Breast International Group: 1Genentech, Inc.: 1Genentech, Inc.: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Clinical Trials Conditions at Kumamoto Shinto General Hospital; Breast Cancer Center


According to Clinical.Site data, the most researched conditions in "Kumamoto Shinto General Hospital; Breast Cancer Center" are "Breast Cancer" (2 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Kumamoto Shinto General Hospital; Breast Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Kumamoto Shinto General Hospital; Breast Cancer Center


Most popular intervention types in "Kumamoto Shinto General Hospital; Breast Cancer Center" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (3 trials), "Pertuzumab" (3 trials), "Trastuzumab" (3 trials), "5-Fluorouracil" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Kumamoto Shinto General Hospital; Breast Cancer Center


The vast majority of trials in "Kumamoto Shinto General Hospital; Breast Cancer Center" are 3 trials for "All" genders.

Clinical Trials Status at Kumamoto Shinto General Hospital; Breast Cancer Center


Currently, there are NaN active trials in "Kumamoto Shinto General Hospital; Breast Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kumamoto Shinto General Hospital; Breast Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kumamoto Shinto General Hospital; Breast Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 3Phase 3: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2Active, not recruiting: 1Active, not recruiting: 1